Types segmentation differentiates hemostatic clips by material composition and functional architecture, each influencing procurement volume and price tier. Metallic clips dominate the market, representing approximately 55 % of units sold; within this class, titanium variants (≈35 %) are preferred for their radiopacity and biocompatibility, while stainless‑steel models (≈20 %) serve cost‑sensitive segments. Polymeric clips account for roughly 30 % of the market, driven by bioabsorbable designs (≈18 %) that eliminate long‑term foreign‑body presence, and polymer‑coated metallic hybrids (≈12 %) that combine mechanical strength with reduced tissue irritation. A niche hybrid clip segment, integrating shape‑memory alloys with biodegradable polymers, contributes the remaining 15 % and is expanding in minimally invasive cardiac applications where controlled deployment is critical. The distribution of these type‑level shares directly shapes the overall market size, as higher‑priced titanium and bioabsorbable products lift average selling prices, while stainless‑steel and standard polymer clips sustain volume growth in emerging economies. Regulatory scrutiny varies, as bioabsorbable devices often undergo extended clinical validation, affecting market entry timelines.
